Cancer survival rates among the best in the nation.
Better survival rates, more moments.
Includes stages with at least 30 patients only.
*Data source: UCHealth Cancer Registry data. National: 2025 American Cancer Society Facts and Figures.
Leaders in research
Learn more about how our expertise has led to breakthroughs in the field of cancer research, treatment and innovation.
Clinical trials and research programs
UCHealth works with our research partner, University of Colorado Anschutz Cancer Center on a multitude of research programs and provide the widest access to clinical trials in Colorado with more than 14,000 participants per year. As the subject-matter experts on many rare cancers, we are not only leading the research, we are teaching it. This is where future lifesaving FDA-approved treatments originate. To us, more leading-edge treatment options mean patients get to enjoy more of life’s moments.
We are a not-for-profit organization comprised of disease-specific specialists focused on advancing care for patients both in and out of trials so they have a better chance of survival. Providing support across the entire spectrum of care including prevention, screening, diagnostics and Phase II/III trials, we are the only cancer program in the state to offer trials supported by the National Cancer Institute (NCI), further establishing our position as a leader in research-driven cancer treatment right here in Colorado.
The only National Cancer Institute (NCI) Comprehensive Cancer Center in Colorado
Of the 73 NCI-Designated Cancer Centers, our research partners at the CU Anschutz Cancer Center are one of the 57 Comprehensive Cancer Centers in the U.S., and the only one in Colorado. This designation recognizes our leadership, resources and an exceptional range of research that spans basic, clinical, prevention, cancer control and population science.
The only National Comprehensive Cancer Network member in Colorado
Our partners at the CU Anschutz Cancer Center are one of 33 National Comprehensive Cancer Network (NCCN) cancer centers in the U.S. and the only one in Colorado. According to the NCCN, their members are globally recognized for treating all types of cancer, including rare and complex cases. They use a team-based approach and lead research that advances care. NCCN programs connect patients with experts, innovative treatments and quality-focused care.
The Gates Institute (TGI)
The Gates Institute (TGI) is a world-class translational research institute located at the University of Colorado Anschutz Medical Campus whose main goal is to transform scientific discoveries into real-world patient cures.
Among the biggest impacts TGI has had on oncology is its contribution to cell-based therapies, especially CAR T-cell immunotherapy, and providing these treatments to patients in clinical trials.
TGI works with the CU Anschutz Cancer Center to innovate the next generation of CAR T therapies targeting solid tumors and other hard-to-treat cancers not addressed by current treatment methods. To learn more about and find current clinical trials happening at the CU Anschutz Cancer Center, visit our research study directory.
Multidisciplinary Care Approach (MDC)
The depth of our scientific and medical knowledge can only benefit the patient if we’re all working together.
Cancer treatment is complex, so it often requires communication and coordination between multiple providers, from surgical, medical and radiation oncologists to pathologists, dietitians, genetic counselors and others. A patient might see multiple specialists in a single day, and in some cases, have more than 50 experts involved in their evaluations.
With the Multidisciplinary Care (MDC) approach, the care team meets face-to-face to establish a cohesive treatment plan. We use MDC to improve collaboration and decision-making to ensure the best possible care for each patient.
Learn more about our survival rates for each type of cancer.
*SEER survival rate is for persons diagnosed between 2013–2019
Locations
